ClinicalTrials.Veeva

Menu

Central and Peripheral Changes in Quadriceps Femoris Function After Different Types of Isometric Strength Training

U

University of Belgrade

Status

Completed

Conditions

Quadriceps Muscle Function

Treatments

Other: Isometric training with voluntary activation
Other: Isometric training with combination of electromyostimulation and voluntary activation
Other: Isometric training with electromyostimulation

Study type

Interventional

Funder types

Other

Identifiers

NCT04624438
02-672-2/09-04-2015

Details and patient eligibility

About

The purpose of this investigation is to examine the effects of 6-week unilateral isometric training interventions over quadriceps femoris on maximal strength and RFD-SF parameters and cortical excitability. Isometric strength training involved either electromyostimulation, voluntary activation, or the combination of both. The second aim is to investigate the potential cross-over effect on a non-trained leg.

Full description

A longitudinal pre-post design with random assignment of the participants to one of three experimental groups or the control group was used. Quadriceps femoris (QF) function and cortical excitability were assessed on four occasions: prior to the intervention (pre-test), after 3 weeks of training (served for the adjustment of exercise intensity), after 6 weeks of training (post-test), and three weeks after the competition of training intervention (detraining) (Figure 1). Isometric strength training involves activation of QF applying EMS, VOLUNTARY, or the combination of both EMS and VOLUNTARY (COMBINED). The pre-test also served to familiarize participants with the training protocols and to determine the intensity of EMS needed to achieve 60%MVC. Quadriceps femoris (QF) function was assessed by MVC and RFD-SF. Cortical excitability was assessed with transcranial magnetic stimulation applied over the M1 region. Prior to the pretest, body mass and percent of body fat were assessed using a bioelectric impedance method (In Body 720; USA) and body height with a standard stadiometer. After the pretest, the participants were randomly assigned to either one of the experimental groups (EMS, VOLUNTARY, or COMBINED) and the control group (CONTROL). Experimental groups performed unilateral isometric strength training three times per week for 6 weeks. All participants were advised to refrain from all resistance training targeting the legs between pre-test and post-test.

Enrollment

52 patients

Sex

All

Ages

19 to 30 years old

Volunteers

Accepts Healthy Volunteers

Inclusion criteria

  • young healthy, physically active participants of both genders

Exclusion criteria

  • no history of injuries, muscle-skeletal or neurological disease, or medications intake

Trial design

Primary purpose

Basic Science

Allocation

Randomized

Interventional model

Factorial Assignment

Masking

None (Open label)

52 participants in 4 patient groups

Electromyostimulation - EMS
Experimental group
Description:
Experimental group comprised of healthy young adults that undergoes unilateral isometric training using electromyostimulation over quadriceps femoris
Treatment:
Other: Isometric training with electromyostimulation
Voluntary activation - VOLUNTARY
Experimental group
Description:
Experimental group comprised of healthy young adults that undergoes unilateral isometric training based on voluntary activation of quadriceps femoris
Treatment:
Other: Isometric training with voluntary activation
Combination of EMS and VOLUNTARY - COMBINED
Experimental group
Description:
Experimental group comprised of healthy young adults that undergoes unilateral isometric training that combines electromyostimulation and voluntary activation of quadriceps femoris.
Treatment:
Other: Isometric training with combination of electromyostimulation and voluntary activation
Control group - CONTROL
No Intervention group
Description:
Group of healthy young adults who received no intervention.

Trial contacts and locations

1

Loading...

Data sourced from clinicaltrials.gov

Clinical trials

Find clinical trialsTrials by location
© Copyright 2026 Veeva Systems